Life Sciences, Healthcare & Pharmaceuticals
Cannabis Desk
Herzog Fox & Neeman's vast, unique cannabis desk offers a range of strategic and legal services, both locally and internationally.
We represent clients in Israel and abroad, specialising in assisting clients at all stages of the supply chain; growth, production, marketing and distribution, and issue.
Our diverse services include:
- assistance and advice throughout the process of obtaining approvals and licences (in Israel and abroad);
- representation before various regulators (in Israel and abroad);
- local and international mergers and acquisitions;
- local and international investment transactions;
- commercial agreements (distribution and cooperation) (including initial public offerings (IPO));
- merger into existing stock exchanges;
- dual listing;
- mass financing;
- ongoing consulting for public and private companies;
- tax consulting, together with advice on the establishment of the various systems and stages of operations;
- medical patents and trademarks, and more.
The multidisciplinary approach advocated by our firm and the vast experience of its diverse departments provide an optimal solution for our clients in maintaining and expanding their business, including later employment agreements, supplier and consultant contracts, construction agreements, licensing, financing and any other task required for growing, and developing businesses in general, and in the relevant field in particular (whether in organic growth or in growth through mergers and acquisitions).
In order to provide full and optimal support to the cannabis bodies at various stages, our office is in direct contact with cannabis regulatory bodies in Israel and abroad, with foreign law firms leading the cannabis industry in their country, and with research and pharma entities located at the forefront of cannabis technology.
Cannabis Desk News & Insights
Exciting News! We’re proud to announce our contribution to the Chambers and Partners Global Practice Guide for Medical Cannabis &
Global Practice Guide for Medical Cannabis & Cannabinoid Regulation in Israel 202
In recent months, the medical cannabis market in Israel has undergone significant upheavals and changes. The war and its damages
Adi Rozenfeld Featured in an Article on the Changes in Israel’s Medical Cannabis Market
Happy Holidays! Wishing you and your loved ones health and happiness in the new year. May 2023 be an extraordinary
Happy Holidays !
We recently represented Pharm Yarok, Rosen High Way, and HW Shinua in their sale to IMC. Pharm Yarok operates a well-known cannabis dispensary in Israel,
Herzog represented Pharm Yarok, Rosen High Way, and HW Shinua in their sale to IMC
Our clients, Kanabo Research, which develops medical cannabis products, were the first cannabis-related company to go public on the London
Our clients, Kanabo Research, were the first cannabis-related company to go public on the London Stock Exchange
Our Client, TelCann LTD, a licensed medical cannabis cultivator, has signed a substantial agreement with Canonic, a company focused on
Our Client TelCann LTD, has signed a substantial agreement with Canonic.
We want to thank you all for tackling the challenges of 2020 with us and hope that in 2021 we
Have a Happy and Healthy New Year 2021
We are excited for our client Cannabotech – The Botanical Pharmacy, which develops innovative medical and pre-medical products based on cannabis
We are excited for our client Cannabotech – The Botanical Pharmacy
As you know, Israel continues its efforts to deal with the Corona Virus and contain it, to avoid its spreading
Handling the Corona Virus- Live Updates
The Israel Securities Authority (the “ISA”) and the Tel Aviv Stock Exchange (“TASE”) have recently approved the listing of companies
Special Cannabis Update | Recreational Cannabis Companies Granted Permission to List on the Tel Aviv Stock Exchange
On May 2, 2019, the United States Patent and Trademark Office (the “USPTO”) issued new guidelines with respect to the